InvestorsHub Logo

genisi

07/25/14 4:11 AM

#180704 RE: jq1234 #180699

Thanks for digging the figures. I assume the 30% medicare should grow in time and help Anoro.

jq1234

08/06/14 7:12 PM

#181008 RE: jq1234 #180699

THRX/GSK - Breo/Anoro Formulary Status Change announced in THRX 2Q2014 Result

Breo:

In early August 2014, the two largest Pharmacy Benefit Managers (PBMs) in the U.S., Express Scripts and CVS Caremark, announced important product updates to their commercial formularies. CVS Caremark will move BREO® ELLIPTA® from its current non-formulary position to a Tier 3 unrestricted position effective January 1, 2015. Express Scripts will move BREO® ELLIPTA® from its current Tier 3 position on the Basic Formulary to a preferred, Tier 2 unrestricted position effective January 1, 2015.



Anoro:

In early August 2014, U.S. Pharmacy Benefit Managers (PBMs), Express Scripts and CVS Caremark, announced important product updates to their commercial formularies. CVS Caremark will move ANORO® ELLIPTA® from its current Tier 3, non-preferred position to a preferred, Tier 2 unrestricted position effective October 1, 2014. Express Scripts has moved ANORO® ELLIPTA® from its current Tier 3, non-preferred position to a preferred, Tier 2 unrestricted position on the National Preferred Formulary and Basic Formulary effective August 1, 2014.



http://investor.thrxinc.com/releasedetail.cfm?ReleaseID=864768